Please join us for a #BPIAskTheExpert on "From Concept to Cleanroom: Case Studies in Single-Use Fluid Management Collaboration." Navigating the complexities of #singleuse #bioprocessing involves managing numerous components, addressing inefficiencies, mitigating #supplychain risks, and budget constraints. Your single-use partner should drive the innovation needed to overcome these challenges and transform ideas from the back of the napkin to your cleanroom floor, so you can focus on delivering life-changing therapeutics quickly and efficiently. This webinar will analyze three case studies, each highlighting different approaches to single-use collaboration. These real-world examples illustrate key considerations when working with single-use suppliers, helping you streamline your processes and prioritize what matters most. Date: Thurs., September 5th. Time: 11 AM ET. Featuring: Greg Verni, Vice President, Fluid Management, Scott Bendon Senior Director of Engineering, Flow Control Technologies, Fluid Management, & Derek Masser, Director of Business and Market Development, Fluid Management, Repligen Corporation. Register Now: https://lnkd.in/gXMe3Yta
BioProcess International
Information Services
Boston, Massachusetts 23,863 followers
brought to you by Informa Connect
About us
BioProcess International™ is a monthly, controlled-circulation magazine devoted to the development, scale-up, and manufacture of biotherapeutics and biodiagnostics. Each issue provides the global industrial biotherapeutic community with up-to-date, peer-reviewed information detailing the business, politics, ethics, applications, products, and services required to successfully drive biopharmaceuticals, vaccines, and biodiagnostics through the development and manufacturing process. BPI is a business unit of Informa Connect https://informaconnect.com
- Website
-
http://www.bioprocessintl.com/
External link for BioProcess International
- Industry
- Information Services
- Company size
- 11-50 employees
- Headquarters
- Boston, Massachusetts
- Type
- Public Company
- Founded
- 2002
- Specialties
- marketing, Biopharmaceutical, biotechnology, print, electronic, online, advertising programs, bioprocessing, vaccines, monoclonal antibodies, protein therapeutics, cell therapies, gene therapy, cell therapy, and biomanufacturing
Locations
-
Primary
2 International Place
Boston, Massachusetts 02110-2601, US
-
One Research Drive
Suite 400A
Westborough, MA 01581, US
-
119 Farringdon Road
London, UK EC1R 3DA, US
-
PO Box 70
Dexter, OR 97431, US
Employees at BioProcess International
Updates
-
Excited to share our latest discussion with Ciaran Brady, Vice President of Manufacturing Science and Technology at Vertex Pharmaceuticals! Find out about industry trends and what’s next for Vertex Pharmaceuticals! Ciaran will be joining us at Cell and Gene Therapy international this September 23-26 at the Hynes Convention Centre, Boston, USA. Visit our website to find out more: https://lnkd.in/d9nmdak #cellandgenetherapy #bioprocessinternational
-
Don't miss our July-August 2024 Platform issue of BioProcess International - available in print and digital! This issue features fascinating articles from talented professionals. Read on for a preview of the articles linked below: Increasing Access Through Continuous Biomanufacturing by Himanshu Gadgil. LC-MS Detection of Host Cell Proteins: Antibody Affinity Extraction Sample Preparation Outperforms Native Digestion by Alla Zilberman, Darren Bertin, Stephen Stahlschmidt, Johanna Barnhill, Timothy Licknack, Jared Isaac, PhD MBA. Write Your Success Story with Tailored Development Platforms by Yeukyung Yoon, Jang Ick Lee. Rare-Disease Research: Its Importance for Orphan-Drug Development Success by Deepti Dubey, Harsha K Rajasimha. Matching Patients with Treatments: Developing Clinically Meaningful Diagnostics To Inform Cancer-Immunotherapy Selection by Brian Gazaille, Ofer Sharon. Smart, Good Manufacturing Practice Production of Cell and Gene Therapies: A Vision for the Future by Sridhar Venkatesan, Jim Beltzer, @Frank Maggiore, Joe Rininger. The Role of Innovation Organizations in the Advanced-Therapies Space by Matthew Durdy. Vocational Schools Build Careers in Bioprocessing Biotechnology by Jared Auclair. Navigating the Commercial Cycle of Biologics Manufacturing by Filippo Pendin. Supply-Chain Challenges in Biotechnology by Sunderesh Heragu. Fostering Digital Transformation in Biomanufacturing: A Conversation About Industry 4.0 Acceptance and Implementation by Brian Gazaille, Yvonne Duckworth, PE, Ryan Thompson. End-to-End Services for Biologics Manufacturing: From Gene to Product by Dr. Thilo Kamphausen, Kai Pohlmeyer. Ensuring Biopharmaceutical Continuity and Sustainability: Tosoh Bioscience’s Strategic Initiatives by Balu Guduri. This issue also features all of our interviews, presentations, and panel discussions with Dan Stanton and Millie Nelson, from the June BPI Theater at BIO 2024 in San Diego, CA. Follow the link below to read the full issue and watch the BPI Theater encore now. https://lnkd.in/gbxG2Duc
BioProcess International July-August 2024 Platform Issue
bioprocessintl.com
-
🚀 Start Up Stories: Meet Shashi Murthy, CTO and Co-Founder of Nanite! 🚀 Nanite combines AI-driven polymer design with multiplexed in vivo screening to develop best-in-class nanoparticles engineered for tissue-specific delivery. Shashi will be joining us at Cell and Gene Therapy International this September 23-26 at the Hynes Convention Centre, Boston, USA. Find out more about Cell and Gene Therapy International here: https://lnkd.in/d9nmdak Learn more about their journey and impact! #Innovation #Startup #CellandGene
-
Please join us for a #BPIAskTheExpert on "Purification Tools to Address Low Yield Challenges with Protein A for the Manufacturing of Bispecifics and Other Modern Antibody Designs." A record number of novel #mAbs, BsAb, and mAb fragments are entering clinical studies. #Manufacturing of these new modalities requires a robust downstream #purification process that produces high yield, purity, and productivity much like its mAb predecessor. Learn about a novel affinity #chromatography technology developed to address purification needs of modern engineered antibodies and mAb fragments. Date: Thurs., August 29th. Time: 11 AM ET. Featuring: Chiu Lau-Barre, Application Staff Scientist, Thermo Fisher Scientific. Register Now: https://lnkd.in/gRnY29qZ
Purification Tools to Address Low Yield Challenges with Protein A for the Manufacturing of Bispecifics and Other Modern Antibody Designs
bpi.bioprocessintl.com
-
We recently had the pleasure of sitting down with Amir Hefni, CEO of Resolution Therapeutics, to discuss their incredible work in macrophage cell therapy. Resolution Therapeutics is developing a macrophage cell therapy product to treat patients at risk of liver decompensation, helping people to avoid the need for a liver transplant. Amir will be joining us at Cell and Gene Therapy International this September 23-26 at the Hynes Convention Centre, Boston, USA. Find out more about Cell and Gene Therapy International here: https://lnkd.in/d9nmdak #BioProcessInternational #CellandGeneTherapyInternational #Innovation
-
Please join us for a #BPIAskTheExpert on "Reliable Data, Reliable Products: Maintaining Data Integrity in Bioprocessing Workflows." In today's regulated #bioprocessing environments, maintaining #dataintegrity is critical for maintaining confidence in the development and #manufacture of your therapeutic. This #webinar will explore the principles of data integrity compliance, presenting best practices and technological solutions, such as the OsmoTECH® XT Single-Sample Micro-Osmometer, to help laboratories overcome these challenges and ensure reliable results, while meeting #regulatory requirements. Date: Tues., August 27th. Time: 11 AM ET. Featuring: Shweta Nair, Senior Product Manager, Biopharma, Advanced Instruments, LLC. Register Now: https://lnkd.in/gV9Vj6zE
Reliable Data, Reliable Products: Maintaining Data Integrity in Bioprocessing Workflows
bpi.bioprocessintl.com
-
Understand how to apply today's leading strategic approaches for cost-effective and scalable biologics manufacturing by attending the upcoming BioProcess International Conference & Exhibition, held September 23-26, 2024 in Boston. Our Manufacturing Strategy track gathers top biopharma experts to show you how to accelerate timelines, boost efficiency, and improve sustainability. Featured presentations include: Agility and Flexibility in Supply Chain Management: Harnessing Digital Innovation to Drive Rapid Response to Market Volatility and Unexpected Challenges Imara Charles Ph.D, VP, Process and Digital Excellence, Global Supply Chain at Bristol Myers Squibb Regulatory Science Perspective on Implementing Industry 4.0 James Coburn, Senior Advisor for Emerging Technologies at FDA’s Office of Counterterrorism and Emerging Threats at FDA When a Template isn't Templated: Bioprocessing in the World of Vaccines Chase Orsello, Global Head, Bioprocess Development at Sanofi Lessons Learned During the Commercialization of Casgevy™, the First CRISPR-Cas 9 Derived Therapy to be Commercially Approved Ciaran Brady, Vice President – Manufacturing Science and Technology (MS&T) at Vertex Pharmaceuticals Register your team to attend this year's event by this Friday, August 23 to save $400 per person. View the full agenda and register today at https://lnkd.in/eYg-uZrV #BPIevent #BiotechWeekBoston Informa Connect Life Sciences
-
-
🚀 Start Up Stories: Meet Eris Jordan, Vice President of Clinical and Medical Affairs at Aurion Biotech! 🚀 Aurion Biotech are a clinical-stage biotech company. They aim to restore vision to all who need it by developing a platform of innovative, accessible, and effective advanced therapies. Eris will be joining us at Cell and Gene Therapy International this September 23-26 at the Hynes Convention Centre, Boston, USA. Find out more about Cell and Gene Therapy International here: https://lnkd.in/d9nmdak Learn more about their journey and impact! #Innovation #Startup #CellandGene
-
The latest episode of the Voices of Biotech #podcast is here! This episode features Carol Houts, Chief Strategy Officer, Germfree and Josh Ludwig, Global Director, Commercial Operations, ScaleReady. Together, they discuss how #sustainability measures can increase patient care and access through decentralized #manufacturing models, which can reduce the time, space, and cost associated with producing #cellandgenetherapies and other modalities. Listen to the full episode here: https://lnkd.in/gnpNKDPa
Podcast: Sustainability is about health equity, says ScaleReady and Germfree
bioprocessintl.com